130 related articles for article (PubMed ID: 34023857)
1. Pancreatic tumor initiation: the potential role of IL-33.
Huang X; Zhang G; Liang T
Signal Transduct Target Ther; 2021 May; 6(1):204. PubMed ID: 34023857
[No Abstract] [Full Text] [Related]
2. [Detection of mutated ras-oncogene in pancreatic cancers: improved diagnostic possibilities using molecular biology techniques?].
Herzig KH; Schäffer M; Rosewicz S; Fölsch UR
Z Gastroenterol; 1992 Jun; 30(6):436-9. PubMed ID: 1636278
[TBL] [Abstract][Full Text] [Related]
3. [Significance of ras mutations in pancreatic diseases].
Löhr M; Liebe S; Lowenfels AB
Z Gastroenterol; 1998 Oct; 36(10):929-32. PubMed ID: 9846373
[No Abstract] [Full Text] [Related]
4. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.
Bishehsari F; Zhang L; Barlass U; Preite NZ; Turturro S; Najor MS; Shetuni BB; Zayas JP; Mahdavinia M; Abukhdeir AM; Keshavarzian A
Int J Cancer; 2018 Oct; 143(8):1994-2007. PubMed ID: 29756386
[TBL] [Abstract][Full Text] [Related]
5. Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.
Hermann PC; Sancho P; Cañamero M; Martinelli P; Madriles F; Michl P; Gress T; de Pascual R; Gandia L; Guerra C; Barbacid M; Wagner M; Vieira CR; Aicher A; Real FX; Sainz B; Heeschen C
Gastroenterology; 2014 Nov; 147(5):1119-33.e4. PubMed ID: 25127677
[TBL] [Abstract][Full Text] [Related]
6. Development of thymic tumor in [LSL:Kras
Liot S; El Kholti N; Balas J; Genestier L; Verrier B; Valcourt U; Lambert E
Sci Rep; 2021 Jul; 11(1):15075. PubMed ID: 34302028
[TBL] [Abstract][Full Text] [Related]
7. [Mutations of the Ki-ras gene: an early event in pancreatic carcinogenesis].
Knoll MR; Singer MV
Z Gastroenterol; 1994 Jul; 32(7):420-1. PubMed ID: 7975782
[No Abstract] [Full Text] [Related]
8. The KRAS
Nat Med; 2022 Oct; 28(10):2017-2018. PubMed ID: 36207523
[No Abstract] [Full Text] [Related]
9. Induction of Pancreatic Inflammation Accelerates Pancreatic Tumorigenesis in Mice.
Zhuang L; Zhan X; Bi Y; Ji B
Methods Mol Biol; 2019; 1882():287-297. PubMed ID: 30378063
[TBL] [Abstract][Full Text] [Related]
10. Important role of Nfkb2 in the Kras
Hassan Z; Schneeweis C; Wirth M; Müller S; Geismann C; Neuß T; Steiger K; Krämer OH; Schmid RM; Rad R; Arlt A; Reichert M; Saur D; Schneider G
Pancreatology; 2021 Aug; 21(5):912-919. PubMed ID: 33824054
[TBL] [Abstract][Full Text] [Related]
11. Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.
Liao J; Chung YT; Yang AL; Zhang M; Li H; Zhang W; Yan L; Yang GY
Mol Carcinog; 2013 Sep; 52(9):739-50. PubMed ID: 22549877
[TBL] [Abstract][Full Text] [Related]
12. Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer.
Weyandt JD; Lampson BL; Tang S; Mastrodomenico M; Cardona DM; Counter CM
PLoS One; 2015; 10(10):e0140253. PubMed ID: 26452271
[TBL] [Abstract][Full Text] [Related]
13. Intratumor Heterogeneity of KRAS Mutation Status in Pancreatic Ductal Adenocarcinoma Is Associated With Smaller Lesions.
Nagawkar SS; Abu-Funni S; Simon E; Bick T; Prinz E; Sabo E; Ben-Izhak O; Hershkovitz D
Pancreas; 2016 Jul; 45(6):876-81. PubMed ID: 26646269
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of K-ras and p53 expression in pancreatic adenocarcinoma using the cancer genome atlas.
Lu L; Zeng J
PLoS One; 2017; 12(7):e0181532. PubMed ID: 28742845
[TBL] [Abstract][Full Text] [Related]
15. Intraductal Oncocytic Papillary Neoplasms of the Pancreas.
Kallen ME; Naini BV
Arch Pathol Lab Med; 2016 Sep; 140(9):992-6. PubMed ID: 27575268
[TBL] [Abstract][Full Text] [Related]
16. miR-802 Suppresses Acinar-to-Ductal Reprogramming During Early Pancreatitis and Pancreatic Carcinogenesis.
Ge W; Goga A; He Y; Silva PN; Hirt CK; Herrmanns K; Guccini I; Godbersen S; Schwank G; Stoffel M
Gastroenterology; 2022 Jan; 162(1):269-284. PubMed ID: 34547282
[TBL] [Abstract][Full Text] [Related]
17. ARID1A suppresses malignant transformation of human pancreatic cells via mediating senescence-associated miR-503/CDKN2A regulatory axis.
Li ZY; Zhu SS; Chen XJ; Zhu J; Chen Q; Zhang YQ; Zhang CL; Guo TT; Zhang LM
Biochem Biophys Res Commun; 2017 Nov; 493(2):1018-1025. PubMed ID: 28942143
[TBL] [Abstract][Full Text] [Related]
18. IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.
Garcia MN; Grasso D; Lopez-Millan MB; Hamidi T; Loncle C; Tomasini R; Lomberk G; Porteu F; Urrutia R; Iovanna JL
J Clin Invest; 2014 Nov; 124(11):4709-22. PubMed ID: 25250570
[TBL] [Abstract][Full Text] [Related]
19. Hes1 plays an essential role in Kras-driven pancreatic tumorigenesis.
Nishikawa Y; Kodama Y; Shiokawa M; Matsumori T; Marui S; Kuriyama K; Kuwada T; Sogabe Y; Kakiuchi N; Tomono T; Mima A; Morita T; Ueda T; Tsuda M; Yamauchi Y; Sakuma Y; Ota Y; Maruno T; Uza N; Uesugi M; Kageyama R; Chiba T; Seno H
Oncogene; 2019 May; 38(22):4283-4296. PubMed ID: 30705405
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA TP53TG1 promotes pancreatic ductal adenocarcinoma development by acting as a molecular sponge of microRNA-96.
Zhang Y; Yang H; Du Y; Liu P; Zhang J; Li Y; Shen H; Xing L; Xue X; Chen J; Zhang X
Cancer Sci; 2019 Sep; 110(9):2760-2772. PubMed ID: 31325400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]